Literature DB >> 17315195

Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma.

Takeshi Ogino1, Shigetaka Moriai, Yoshiya Ishida, Hideyuki Ishii, Akihiro Katayama, Naoyuki Miyokawa, Yasuaki Harabuchi, Soldano Ferrone.   

Abstract

We have investigated the association of immunoescape mechanisms in nasopharyngeal carcinoma (NPC) lesions with Epstein-Barr virus (EBV) infection and clinical course of the disease. Tumor biopsy specimens obtained from 36 Japanese NPC patients were examined for antigen processing machinery component and HLA class I antigen expression, CD8(+) T cell infiltration, and Fas, Fas ligand (FasL) and IL-10 expression using immunohistochemical staining. The results were correlated with the histopathological characteristics of the lesions, the clinical course of the disease and EBV infection. LMP2, TAP1, tapasin and HLA class I antigens were downregulated in more than 65% of the lesions tested, while FasL, Fas and IL-10 were expressed in at least 60% of the lesions. Statistical analysis showed that (i) HLA class I antigen expression was significantly correlated with LMP2 and tapasin expression (r = 0.39 and 0.45, respectively); (ii) CD8(+) T cell infiltration into tumor lesions was significantly correlated with HLA class I antigen, LMP2 and Fas expression (r = 0.34, 0.49 and 0.44, respectively); (iii) LMP2 and FasL expression was significantly correlated with IL-10 expression (r = 0.49 and 0.52, respectively); (iv) IL-10 expression was significantly associated with EBERs and EBV oncoprotein LMP1 expression (p = 0.00078 and 0.015, respectively) and (v) FasL overexpression was significantly associated with reduced patients' survival (p = 0.033). Multivariate analysis identified FasL overexpression as an independent unfavorable prognostic marker. These results suggest that NPC cells may utilize multiple immunoescape mechanisms, including dysfunction of HLA class I antigens and Fas/FasL apoptosis pathways. Furthermore, FasL expression appears to be associated with IL-10 upregulation in EBV positive NPC cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17315195     DOI: 10.1002/ijc.22334

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses.

Authors:  Jennifer Yinuo Cao; Sheila Mansouri; Lori Frappier
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 2.  Immune escape by Epstein-Barr virus associated malignancies.

Authors:  Christian Münz; Ann Moormann
Journal:  Semin Cancer Biol       Date:  2008-10-19       Impact factor: 15.707

3.  Immune regulation and evasion of Mammalian host cell immunity during viral infection.

Authors:  B M Pratheek; Soham Saha; Prasanta K Maiti; Soma Chattopadhyay; Subhasis Chattopadhyay
Journal:  Indian J Virol       Date:  2013-03-15

4.  Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma.

Authors:  Yong Zheng; Greg Parsonage; Xiaodong Zhuang; Lee R Machado; Christine H James; Asmaa Salman; Peter F Searle; Edwin P Hui; Anthony T C Chan; Steven P Lee
Journal:  Cancer Immunol Res       Date:  2015-02-24       Impact factor: 11.151

Review 5.  Prognostic significance of tumor-infiltrating lymphocytes and macrophages in nasopharyngeal carcinoma: a systematic review and meta-analysis.

Authors:  Weixing Liu; Chunyi Zhang; Gui Chen; Xiao Liao; Junyang Xie; Tianhao Liang; Wenjing Liao; Lijuan Song; Xiaowen Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-24       Impact factor: 2.503

6.  Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes.

Authors:  Peng Liu; Bai-Lu Xie; Shao-Hui Cai; Yun-Wen He; Ge Zhang; Yan-Mei Yi; Jun Du
Journal:  BMC Cancer       Date:  2009-11-30       Impact factor: 4.430

7.  The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.

Authors:  K M Shah; S E Stewart; W Wei; C B J Woodman; J D O'Neil; C W Dawson; L S Young
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

Review 8.  HLA associations with nasopharyngeal carcinoma.

Authors:  Xin Li; Ross Fasano; Ena Wang; Kai-Tai Yao; Francesco M Marincola
Journal:  Curr Mol Med       Date:  2009-08       Impact factor: 2.222

9.  c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells.

Authors:  C S Tudor; C W Dawson; J Eckhardt; G Niedobitek; A C Büttner; B Seliger; A Hartmann; M Buettner
Journal:  Br J Cancer       Date:  2012-05-15       Impact factor: 7.640

10.  Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis.

Authors:  Birhanu Aberha Berele; Yuxiang Cai; Guifang Yang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.